{"id":"https://openalex.org/W2178924775","doi":"https://doi.org/10.1586/17474086.2016.1112735","title":"Economic burden associated with acute myeloid leukemia treatment","display_name":"Economic burden associated with acute myeloid leukemia treatment","publication_year":2015,"publication_date":"2015-11-14","ids":{"openalex":"https://openalex.org/W2178924775","doi":"https://doi.org/10.1586/17474086.2016.1112735","mag":"2178924775","pmid":"https://pubmed.ncbi.nlm.nih.gov/26568358"},"language":"en","primary_location":{"id":"doi:10.1586/17474086.2016.1112735","doi":"https://doi.org/10.1586/17474086.2016.1112735","is_oa":false,"landing_page_url":"https://doi.org/10.1586/17474086.2016.1112735","pdf_url":null,"source":{"id":"https://openalex.org/S73682863","display_name":"Expert Review of Hematology","issn_l":"1747-4086","issn":["1747-4086","1747-4094"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Review of Hematology","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5067521829","display_name":"Amer Methqal Zeidan","orcid":"https://orcid.org/0000-0001-7017-8160","observed_orcids":["https://orcid.org/0000-0001-7017-8160"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Amer M Zeidan","raw_affiliation_strings":["a Department of Internal Medicine , Yale University , New Haven , CT , USA","Department of Internal Medicine, Yale University, New Haven, CT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"a Department of Internal Medicine , Yale University , New Haven , CT , USA","institution_ids":["https://openalex.org/I32971472"]},{"raw_affiliation_string":"Department of Internal Medicine, Yale University, New Haven, CT, USA","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110832301","display_name":"Dalia Mahmoud","orcid":"https://orcid.org/0009-0007-6041-233X","observed_orcids":["https://orcid.org/0009-0007-6041-233X"]},"institutions":[{"id":"https://openalex.org/I4387155837","display_name":"Celgene (United States)","ror":"https://ror.org/0527yg379","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812","https://openalex.org/I4387155837"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dalia Mahmoud","raw_affiliation_strings":["b Celgene Corporation , Summit , NJ , USA","Celgene Corporation, Summit, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"b Celgene Corporation , Summit , NJ , USA","institution_ids":["https://openalex.org/I4387155837"]},{"raw_affiliation_string":"Celgene Corporation, Summit, NJ, USA","institution_ids":["https://openalex.org/I4387155837"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054732597","display_name":"I. Kucmin-Bemelmans","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094451","display_name":"Pharmerit (Netherlands)","ror":"https://ror.org/00ntr9f13","country_code":"NL","type":"company","lineage":["https://openalex.org/I4210094451","https://openalex.org/I4210134090"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Izabela T Kucmin-Bemelmans","raw_affiliation_strings":["c Pharmerit B.V ., Rotterdam , The Netherlands","Pharmerit B.V., Rotterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"c Pharmerit B.V ., Rotterdam , The Netherlands","institution_ids":["https://openalex.org/I4210094451"]},{"raw_affiliation_string":"Pharmerit B.V., Rotterdam, The Netherlands","institution_ids":["https://openalex.org/I4210094451"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109831816","display_name":"Cathelijne Alleman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094451","display_name":"Pharmerit (Netherlands)","ror":"https://ror.org/00ntr9f13","country_code":"NL","type":"company","lineage":["https://openalex.org/I4210094451","https://openalex.org/I4210134090"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Cathelijne JM Alleman","raw_affiliation_strings":["c Pharmerit B.V ., Rotterdam , The Netherlands","Pharmerit B.V., Rotterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"c Pharmerit B.V ., Rotterdam , The Netherlands","institution_ids":["https://openalex.org/I4210094451"]},{"raw_affiliation_string":"Pharmerit B.V., Rotterdam, The Netherlands","institution_ids":["https://openalex.org/I4210094451"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110943052","display_name":"Marja Hensen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094451","display_name":"Pharmerit (Netherlands)","ror":"https://ror.org/00ntr9f13","country_code":"NL","type":"company","lineage":["https://openalex.org/I4210094451","https://openalex.org/I4210134090"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Marja Hensen","raw_affiliation_strings":["c Pharmerit B.V ., Rotterdam , The Netherlands","Pharmerit B.V., Rotterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"c Pharmerit B.V ., Rotterdam , The Netherlands","institution_ids":["https://openalex.org/I4210094451"]},{"raw_affiliation_string":"Pharmerit B.V., Rotterdam, The Netherlands","institution_ids":["https://openalex.org/I4210094451"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111658759","display_name":"Barry Skikne","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387155837","display_name":"Celgene (United States)","ror":"https://ror.org/0527yg379","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812","https://openalex.org/I4387155837"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Barry Skikne","raw_affiliation_strings":["b Celgene Corporation , Summit , NJ , USA","Celgene Corporation, Summit, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"b Celgene Corporation , Summit , NJ , USA","institution_ids":["https://openalex.org/I4387155837"]},{"raw_affiliation_string":"Celgene Corporation, Summit, NJ, USA","institution_ids":["https://openalex.org/I4387155837"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5041542657","display_name":"Benjamin D. Smith","orcid":"https://orcid.org/0000-0001-7866-1093","observed_orcids":["https://orcid.org/0000-0001-7866-1093"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"B Douglas Smith","raw_affiliation_strings":["d Kimmel Cancer Center , Johns Hopkins , Baltimore , MD , USA","Kimmel Cancer Center, Johns Hopkins, Baltimore, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"d Kimmel Cancer Center , Johns Hopkins , Baltimore , MD , USA","institution_ids":["https://openalex.org/I145311948"]},{"raw_affiliation_string":"Kimmel Cancer Center, Johns Hopkins, Baltimore, MD, USA","institution_ids":["https://openalex.org/I145311948"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5067521829"],"corresponding_institution_ids":["https://openalex.org/I32971472"],"apc_list":null,"apc_paid":null,"fwci":0.7347,"has_fulltext":false,"cited_by_count":55,"citation_normalized_percentile":{"value":0.60167715,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"9","issue":"1","first_page":"79","last_page":"89"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":1.0},{"id":"https://openalex.org/keywords/economic-burden","display_name":"economic burden","score":0.8100000023841858},{"id":"https://openalex.org/keywords/allogeneic-stem-cell-transplantation","display_name":"allogeneic stem cell transplantation","score":0.9169999957084656},{"id":"https://openalex.org/keywords/intensive-chemotherapy","display_name":"intensive chemotherapy","score":0.9539999961853027},{"id":"https://openalex.org/keywords/induction-chemotherapy","display_name":"induction chemotherapy","score":0.8899999856948853},{"id":"https://openalex.org/keywords/low-intensity-therapy","display_name":"low-intensity therapy","score":0.906000018119812},{"id":"https://openalex.org/keywords/best-supportive-care","display_name":"best supportive care","score":0.9800000190734863},{"id":"https://openalex.org/keywords/health-care-costs","display_name":"health care costs","score":0.5600000023841858}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8952510356903076},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.7328882217407227},{"id":"https://openalex.org/C6964187","wikidata":"https://www.wikidata.org/wiki/Q659256","display_name":"Indirect costs","level":2,"score":0.6551358699798584},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.5709059238433838},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5368542671203613},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.43168455362319946},{"id":"https://openalex.org/C2776611710","wikidata":"https://www.wikidata.org/wiki/Q16888295","display_name":"Induction chemotherapy","level":3,"score":0.4247775673866272},{"id":"https://openalex.org/C2776863199","wikidata":"https://www.wikidata.org/wiki/Q976388","display_name":"Acute leukemia","level":3,"score":0.41876351833343506},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3477332890033722},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.3312663435935974},{"id":"https://openalex.org/C121955636","wikidata":"https://www.wikidata.org/wiki/Q4116214","display_name":"Accounting","level":1,"score":0.0},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1586/17474086.2016.1112735","doi":"https://doi.org/10.1586/17474086.2016.1112735","is_oa":false,"landing_page_url":"https://doi.org/10.1586/17474086.2016.1112735","pdf_url":null,"source":{"id":"https://openalex.org/S73682863","display_name":"Expert Review of Hematology","issn_l":"1747-4086","issn":["1747-4086","1747-4094"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Review of Hematology","raw_type":"journal-article"},{"id":"pmid:26568358","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26568358","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert review of hematology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320309086","display_name":"Celgene","ror":"https://ror.org/0527yg379"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":39,"referenced_works":["https://openalex.org/W30444434","https://openalex.org/W56772273","https://openalex.org/W63719476","https://openalex.org/W1786127249","https://openalex.org/W1978478567","https://openalex.org/W1983905269","https://openalex.org/W1989112475","https://openalex.org/W1994622611","https://openalex.org/W1995804127","https://openalex.org/W2006084386","https://openalex.org/W2006924573","https://openalex.org/W2018824417","https://openalex.org/W2019789605","https://openalex.org/W2049132251","https://openalex.org/W2051460267","https://openalex.org/W2060611938","https://openalex.org/W2061191647","https://openalex.org/W2063354554","https://openalex.org/W2075620217","https://openalex.org/W2077251479","https://openalex.org/W2081576971","https://openalex.org/W2093771369","https://openalex.org/W2098262440","https://openalex.org/W2112998845","https://openalex.org/W2129762659","https://openalex.org/W2134406533","https://openalex.org/W2138346558","https://openalex.org/W2175403179","https://openalex.org/W2189011831","https://openalex.org/W2316392947","https://openalex.org/W2319262182","https://openalex.org/W2326110955","https://openalex.org/W2332271831","https://openalex.org/W2409737022","https://openalex.org/W2412489121","https://openalex.org/W2415833732","https://openalex.org/W2553008980","https://openalex.org/W2563362963","https://openalex.org/W2916269123"],"related_works":["https://openalex.org/W2553008980","https://openalex.org/W1983905269","https://openalex.org/W4409119385","https://openalex.org/W4394750730","https://openalex.org/W3198057171","https://openalex.org/W4318566983","https://openalex.org/W4387748135","https://openalex.org/W2994907460","https://openalex.org/W3157880997","https://openalex.org/W3015554812"],"abstract_inverted_index":{"The":[0,14],"economic":[1,137,148],"burden":[2],"associated":[3,94,133],"with":[4,95,134],"acute":[5],"myeloid":[6],"leukemia":[7],"(AML)":[8],"is":[9,19],"poorly":[10],"defined":[11],"and":[12,33,44,79,155],"understudied.":[13],"goal":[15],"of":[16,24,57],"this":[17],"study":[18],"estimate":[20],"the":[21,29,34,46,53,86,96,109,120,147],"direct":[22,48,98,101,136],"cost":[23],"illness":[25],"for":[26,52,112,116,124],"AML":[27,129],"in":[28,108,119,151],"United":[30,35],"States":[31],"(US)":[32],"Kingdom":[36],"(UK),":[37],"by":[38,62,70,90],"conducting":[39],"a":[40],"comprehensive":[41],"literature":[42],"review":[43],"calculating":[45],"average":[47],"cost-of-illness":[49],"per":[50],"patient":[51],"first":[54],"6":[55],"months":[56],"therapy.":[58],"Patients":[59],"were":[60],"grouped":[61],"therapy:":[63],"intensive":[64,91],"chemotherapy":[65,68],"alone;":[66],"induction":[67],"followed":[69,89],"allogeneic":[71],"stem":[72],"cell":[73],"transplantation":[74],"(alloSCT);":[75],"low":[76],"intensity":[77],"therapy;":[78],"best":[80],"supportive":[81],"care.":[82],"Data":[83],"suggest":[84,103],"that":[85,104],"pathways":[87],"alloSCT,":[88],"chemotherapy,":[92],"are":[93,106,142],"highest":[97],"costs.":[99,157],"Calculated":[100],"costs":[102],"they":[105],"higher":[107],"US":[110],"($14,014":[111],"BSC-only":[113,125],"to":[114,126,131,144,153],"$352,682":[115],"alloSCT)":[117],"than":[118],"UK":[121],"(\u00a33708":[122],"[$5837]":[123],"\u00a3112,545":[127],"[$177,187]).":[128],"appears":[130],"be":[132],"significant":[135],"costs,":[138],"but":[139],"more":[140],"studies":[141],"needed":[143],"fully":[145],"assess":[146],"impact":[149],"especially":[150],"relation":[152],"total":[154],"indirect":[156]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":12},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2016-06-24T00:00:00"}